PATENT CLAIM ANALYSIS

Application Number: 16277785
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "362000"]

Abstract:
The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits a different biological membrane crossing rate as compared to the biological membrane crossing rate of the small molecule drug not attached to the water-soluble oligomer.

Claim (Index 31):
A method comprising covalently attaching a water-soluble, non-peptidic oligomer to a beta blocker.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.55
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12530412', '15690106', '12674139', '14266317', '13319924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7710676097755623
- 35 USC 102 Novelty (BERT): 0.5265023941427045
- Combined Prediction Score: 0.7466110882122766
- Mean Citation Score: 298.73018799999994
- Max Citation Score: 345.89764
- Similarity Product: 256.2062604885054

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test